Close Menu

NEW YORK  – Thermo Fisher Scientific on Wednesday morning reported a 2 percent year-over-year increase in its first quarter 2020 revenues.

Earlier this month, the Waltham, Massachusetts-based company had predicted a 1 to 2 percent increase in Q1 revenues but withdrew its financial guidance for 2020. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.